Presenter: Dr. Claire Loden, DNP, FNP-C
Related Chapters:
Chapter 49: Management of Patients with Urinary Disorders
Chapter 53: Assessment and Management of Patients with Male Reproductive Disorders
Fall in love with Jesus
Quote: "The Lord is my shepherd; I shall not want." - Psalm 23:1
Understand the disease process, nursing considerations, and interventions.
Identify appropriate treatment methods and pharmacotherapy interventions.
Identify appropriate patient education discussion points for each disease process.
Acute Prostatitis
Benign Prostatic Hypertrophy (BPH)
Prostate Cancer
Testicular Cancer
Orchitis
Epididymitis
Testicular Torsion
Erectile Dysfunction
Priapism
Bladder Cancer
Key Structures:
Symphysis pubis
Vas deferens
Corpus cavernosum
Urinary bladder
Ampulla
Seminal vesicle
Ejaculatory duct
Prostate gland
Bulbourethral gland
Anus
Perineum
Penis
Urethra
Glans penis
Prepuce
Urethral meatus
Scrotum
Epididymis
Definition: Painful inflammation of the prostate.
Key Highlights:
Most frequent urologic diagnosis in men < 50 years old
Commonly caused by E. Coli
Symptoms include abdominal, ejaculatory, rectal, and perineal pain.
Common Symptoms:
Sudden fever
Discomfort
Burning/urgency
Frequent urination
Pain with ejaculation
Referred pain in genitalia, perineum, lower back, or suprapubic areas.
Diagnosis:
Urinalysis (UA) & culture (CS)
Transrectal ultrasound (to rule out abscess, cysts, or seminal vesicle obstruction).
Treatment:
Antibiotics: Ciprofloxacin or Bactrim
NSAIDs to alleviate bladder spasms
Catheterization as needed.
Patient Education:
Signs and symptoms (S/s) and treatment.
Overview:
Common disease in aging men
Slow enlargement of the prostate due to hypertrophy and hyperplasia, compressing the urethra.
Storage Symptoms:
Frequency
Urgency
Nocturia
Incontinence
Voiding Symptoms:
Weak stream
Dribbling
Dysuria
Straining
Uncommon Symptoms:
Fever with dysuria
Urinary retention
Diagnostic Tests:
UA: normal in uncomplicated BPH
Pyuria indicates UTI
Hematuria may suggest cancer
PSA: elevated levels indicate potential issues and can aid in discussing treatment.
Volume charting: record frequency and volume of voiding for three days.
Medications:
First line treatment: focus on avoiding retention, shrinking the gland, and relaxing smooth muscle
Catheterization: Temporary urinary or straight catheterization if needed.
Behavioral Modifications:
Reduce fluids at night.
Limit caffeine and alcohol
Avoid or adjust timing of diuretics/medications that may increase urinary retention.
Examples:
Tamsulosin & Terazosin: smooth muscle relaxers.
Initial therapy for most patients, effective within days.
"First-dose effect": Increased risk of falls, fractures, and head trauma.
Medications must be titrated; know drug class, MOA, and side effects.
Examples:
Finasteride & Dutasteride
Effectively reduce prostate size and symptoms related to acute urinary retention.
PSA decreases by 50% but may obscure prostate cancer diagnosis.
Monitor for potential side effects like sexual dysfunction in 5-10% of patients.
Transurethral Resection of the Prostate (TURP):
Insert scope via urethra; standard procedure for prostate sizes < 80g.
Excellent resolution of LUTS, but increases risk of bleeding and ejaculatory dysfunction.
Urethral stents for narrowing areas.
Prostatectomy: removal of the inner portion of the prostate.
Most Common Surgical Procedure: Transurethral resection of the prostate (TURP).
Monitor for hemorrhage and perform continuous bladder irrigation.
Assess for TURP syndrome (transurethral resection syndrome).
Provide instructions for discharge and manage bladder spasms.
Definition: Excessive fluid load causing electrolyte shifts and associated symptoms due to absorption of irrigation fluid.
Can lead to complications such as hyponatremia and hypervolemia.
Avoid straining for bowel movements for 6 weeks (use stool softener).
Maintain catheter hygiene and recognize abnormal signs.
Engage in Kegel exercises for bladder control, avoid lifting > 5lbs for 6 weeks.
Resume sexual activity in 3-4 weeks; report any abnormal symptoms to the healthcare provider.
Purpose: Flush blood clots or debris from the bladder post-surgery.
Utilizes a triple-lumen catheter and maintains continuous output; urine should appear pink to clear.
Post TURP and bladder surgery; can also be used for chemotherapy applications and to dissolve bladder stones.
Monitor and titrate to maintain appropriate urine clarity; intervene if obstructions occur (notify MD if unable to relieve).
Characteristics: Slow-growing malignancy, most commonly adenocarcinomas.
Typically arises from the outer area of the prostate and can metastasize to lymphatic and vascular systems.
Risk Factors:
Age
Exposure to heavy metals
Smoking
High-fat diet
Obesity
African American descent
Family history
Sexually transmitted infections (STIs).
Methods:
PSA levels (initial exam at age 40); >4 requires follow-up.
DRE performed alongside baseline PSA to detect nodules or abnormalities.
Diagnostic Tools:
PSA testing, DRE, transrectal ultrasound (TRUS) for biopsy.
Early Symptoms: Often asymptomatic but may present with hard nodules or painless hematuria in advanced disease.
Late Symptoms: Weight loss, urinary obstruction, and bone pain.
Stages:
Stage I: Localized tumor
Stage II: Tumor extended
Stage III: Local metastasis
Stage IV: Distant metastasis.
Options:
Active surveillance, hormone therapy, chemotherapy, radiation (internal/external), proton therapy, prostatectomy.
Close monitoring; treatment only if disease advances.
Regular PSA and DRE requirement for ongoing assessment.
Utilized when hormone therapy fails; not curative, but may improve survival rates in non-androgen-dependent cancers.
Administered to shrink tumors and reduce metastasis, typically in short sessions over several weeks.
Method: Radioactive seed implants into the prostate; minimal radiation exposure outside of the gland in the immediate aftermath.
Patient Care: Monitor for complications like rectal inflammation, bleeding, and urinary issues; safeguard against exposure to vulnerable populations.
Offers fewer side effects, is painless, and leaves surrounding tissues unharmed.
High survival rates at four years.
Types of Approaches: Suprapubic, retropubic, and perineal.
Surgical removal of the prostate tissue for treatment.
Mr. Rodriguez: Identifying symptoms related to benign prostatic hyperplasia, including:
B. Incomplete emptying
D. Hesitancy
E. Intermittent urinary stream
Preoperative: Bowels preparation and clear liquid diet.
Postoperative Monitoring: Check for urine leaks, hemorrhage, and infection.
Critical health concerns regarding male reproductive disorders.
Self-Examination: Monthly testicular self-exam recommended
Types: Germinal and nongerminal cancers.
Symptoms: Painless enlargement, heaviness, inguinal pain, metastasis signs (back ache, weight loss).
Guidelines for self-examinations: check after showering, roll between fingers, look for lumps, and consult a doctor for abnormalities.
Definition: Inflammation of one or both testicles; can be caused by various organisms.
Symptoms: Pain, fever, nausea/vomiting.
Diagnosis: STI screening, UA, ultrasound to rule out torsion.
Treatment: Antibiotics (if bacterial), rest, scrotal support.
Symptoms: Pain and swelling in the back of the testicle, possible enlarged testes.
Diagnostic tests include UA, CBC, and STI testing.
Management: Targeted antibiotics based on organism identification, bed rest, and scrotal elevation.
Definition: Twisting of the spermatic cord, leading to acute pain and blood flow loss to the testicle.
Diagnosis: Typically history of trauma, confirmed via ultrasound.
Surgical Intervention: Urgent untwist of the testicle and suture cord to prevent re-torsion and preserve fertility.
Important symptoms include sudden testicular pain, swelling, and redness, requiring immediate medical attention.
Definition: Inability to achieve or maintain an erection adequate for sexual intercourse, affecting a significant portion of men aged 40-70.
Psychogenic Factors: Include anxiety, depression, and relationship issues.
Organic Factors: Include cardiovascular diseases, diabetes, and certain medications.
Diagnosis: History and physicals, sleep studies.
Treatment Options: Medications (e.g., sildenafil, alprostadil) and mechanical devices.
Definition: Prolonged erection lasting 4-6 hours; can lead to severe complications if untreated.
Treatment: Oral medications, aspiration, and potentially surgery.
Overview: Arises from various sources, predominantly affects men.
Risk Factors: Smoking, chemical exposure, and radiation.
Primary Symptom: Visible, painless hematuria; other symptoms include urgency, frequency, and potential pain.
Cystoscopy: Key tool for visual inspection and biopsy of suspicious lesions.
Methods Include: Radiation therapy, chemotherapy, urinary diversion, and cystectomy as necessary.
Intravesical Chemotherapy: Concentrated treatment instilled into the bladder.
Surgical Interventions: Include transurethral resections and cystectomies.
Key Focus Areas: Monitor urine output, vital signs, stoma assessment, and hydration management post-surgery.
Indications: Used for kidney obstructions from tumors or calculi.
Consists of inserting a nephrostomy tube to relieve obstruction.